BOI:EPA
Boiron USA
19,20 €
arrow_upward
+0,79%(+0,15) 1D
13 նոյ, 17:35:27 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
19,25 €
High
19,25 €
Low
18,95 €
Mkt. cap
330,69 մլն
Avg. vol.
4,88 հզր
Volume
1,71 հզր
P/E ratio
12,73
52-wk high
32,25 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 մլն
No. of employees
3 հզր
Open
19,25 €
High
19,25 €
Low
18,95 €
Mkt. cap
330,69 մլն
Avg. vol.
4,88 հզր
Volume
1,71 հզր
P/E ratio
12,73
52-wk high
32,25 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
Bloomberg.com
·
1 ժամ առաջ
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
Yahoo Finance
·
1 ժամ առաջ
Opinion: Buy This Growth Stock to Beat the S&P 500 in 2027
Trefis
·
7 ժամ առաջ
S&P 500 Movers | Winners: CHTR, STE, GPN | Losers: AMD, DELL, CSCO
Traders Union
·
2 ժամ առաջ
Gold volatility surpasses S&P 500 by 2.1 times, Mike McGlone notes
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron USA